The introduction of TNF inhibitors in 2003 has failed to stop fracture rates in patients with ankylosing spondylitis from more than doubling from 2000 to 2020, according to data published in ...

At 2 years, approximately 6 in 10 patients with either nr-axSpA or AS achieved Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (ASDAS < 2.1), and 3 in 10 achieved a ...

A 5-year study of bimekizumab in ankylosing spondylitis encountered no new safety signals, with efficacy sustained even in a conservative analysis with non-responder imputation, according to data ...

Ankylosing spondylitis (AS) is the second most common type of inflammatory arthritis, often affecting teenagers and young adults. Symptoms of AS can include back pain, stiffness, joint ...

Learn about the differences between ankylosing spondylitis and spondylolisthesis. This article discusses causes, symptoms, treatments, and diagnosis.

Ankylosing spondylitis (AS) is a form of arthritis that affects the spine. People with AS may experience hormonal or bone density changes that can affect their experience during menopause ...

Source Reference: van der Heijde D, et al "Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled ...

Ankylosing spondylitis is a type of arthritis that causes chronic inflammation that affects your spine. As the disease progresses, it leads to the bones fusing together. You could also have bone ...

Well we do have some information about what causes ankylosing spondylitis and other forms of axial spondyloarthritis. We think this is a highly genetic-driven disease, with the primary gene ...

Ankylosing spondylitis can raise your risk of various cardiovascular problems, such as inflammation of the aorta, arrhythmias, atherosclerosis, heart valve disease, and ischemic heart disease.